MAP1LC3A and breast cancer: A 24 h incubation of human breast cancer cells with 5 mM 3-Methyladenine (3-MA), a known autophagy inhibitor, resulted in a reduction in LC3A concentration to 4.423 ng/mL (MCF-7 cells) and 0.994 ng/mL (MDA-MB-231 cells).